<?xml version="1.0" encoding="UTF-8"?>
<p>Even though viral infections pose a significant threat to human health, antivirals to combat them are few and often lead to the development of drug resistance. A strategy to avoid drug resistance is to develop antivirals targeting host cell co-factors critical to viral replication. DDX3X is a prime host target for multiple viruses of medical significance, being required for replication of HIV-1 [
 <xref rid="B5-cells-09-00170" ref-type="bibr">5</xref>,
 <xref rid="B6-cells-09-00170" ref-type="bibr">6</xref>] and flaviviruses such as Japanese encephalitis virus (JEV) [
 <xref rid="B36-cells-09-00170" ref-type="bibr">36</xref>] and HCV [
 <xref rid="B7-cells-09-00170" ref-type="bibr">7</xref>,
 <xref rid="B8-cells-09-00170" ref-type="bibr">8</xref>]. 
</p>
